BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/31/2024 10:42:49 AM | Browse: 52 | Download: 167
 |
Received |
|
2024-08-20 03:21 |
|
Peer-Review Started |
|
2024-09-04 13:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-15 20:25 |
|
Revised |
|
2024-09-20 09:20 |
|
Second Decision |
|
2024-10-14 02:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-14 05:57 |
|
Articles in Press |
|
2024-10-14 05:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-10-20 01:13 |
|
Typeset the Manuscript |
|
2024-10-22 11:18 |
|
Publish the Manuscript Online |
|
2024-10-31 10:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Merve Guney-Coskun and Metin Basaranoglu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Merve Guney-Coskun, Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Medipol University, Kavacık, Göztepe Mah, No. 40 Atatürk Cd, Istanbul 34810, Türkiye. merve.guney@medipol.edu.tr |
| Key Words |
Metabolic dysfunction-associated steatotic liver disease; Glucagon-like peptide-1 receptor agonists; Gut microbiome; Gut-liver axis; Diet intervention |
| Core Tip |
The gut-liver axis is integral to the progression of various diseases, with key metabolites like lipopolysaccharides, short-chain fatty acids, bile-acids, immune factors, inflammatory cytokines, and beneficial bacteria such as Bifidobacterium and Lactobacillus playing pivotal roles. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) contribute to substantial weight loss, enhance insulin secretion, reduce appetite, and improve liver health by restoring gut-liver axis functionality. Dietary modifications can amplify these benefits, while gut microbiome-targeted therapies may offer additional advantages in treating metabolic dysfunction-associated steatotic liver disease. Future multi-omics research will underscore the importance of personalized GLP-1 RAs treatment considering gut microbiota effects, with prebiotics and probiotics potentially improving liver health via the gut microbiota. |
| Publish Date |
2024-10-31 10:42 |
| Citation |
<p>Guney-Coskun M, Basaranoglu M. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. <i>World J Gastroenterol</i> 2024; 30(43): 4682-4688</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i43/4682.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i43.4682 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
